Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors.

Liancheng FanBaijun DongChenfei ChiYanqing WangYiming GongJianjun ShaJiahua PanXun ShangguanYiran HuangLixin ZhouWei Xue

Published in: BMC urology (2018)

These results support the favourable safety and efficacy profile of AA for the treatment of Asian patients with chemotherapy-naive mCRPC. Longer duration of ADT response was significantly associated with longer survival.

Keyphrases

prognostic factors
locally advanced
hiv infected
squamous cell carcinoma
small cell lung cancer
rectal cancer
radiation therapy
chemotherapy induced